# La Esperanza Clinic, Inc.

Health Center, TX
Page: https://astrelis.co/providers/health_center/451902  
This twin: https://astrelis.co/providers/health_center/451902.md  
CMS Certification Number (CCN): 451902  
Release: 2321a4fc37a7 (2026-10-22)

## Headline figures (fiscal years on file: 2019 to 2025)

- **Total patients (UDS) (FY2024):** 11,178. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Total visits (all service types) (FY2024):** 33,701. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Service sites (FY2024):** 5. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Uninsured patient share (FY2024):** 26.7%. Illustrative estimate. Definition: https://astrelis.co/methodology#health-center
- **Operating margin (FY2025):** -15.3%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center
- **Total operating revenue (FY2025):** $3.6M. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Total margin (including nonoperating) (FY2025):** -15.3%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center

## Audited financial statements (Federal Audit Clearinghouse)

Read from the FAC-11 template of the audited statements: every line, every ratio and every status column print as the template carries them, and no figure is withheld. A report's tie status says whether its statements foot; a ratio's plausibility status says whether it sits inside its possible range; a median of fewer than five values says so. The figures were not audited by Astrelis. Contract: https://astrelis.co/methodology/fqhc-audit-contract

### LA ESPERANZA CLINIC, INC., TX

Match to this profile: identifier verified: the EIN the dataset carries for this CCN agrees with the filed EIN (method: exact name and state (FACLAND tier 1)).

- FY ending 2025-12-31 (audit year 2025): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2025-12-GSAFAC-0000430820
- FY ending 2024-12-31 (audit year 2024): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2024-12-GSAFAC-0000373829
- FY ending 2023-12-31 (audit year 2023): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2023-12-GSAFAC-0000059533

| Line | FY ending 2025-12-31 | FY ending 2024-12-31 | FY ending 2023-12-31 |
|---|---:|---:|---:|
| cash and investments (current) (Statement of financial position) | 218,771 [derived, p.6] | 291,658 [derived, p.6] | 1,411,105 [derived, p.6] |
| patient receivables, net (Statement of financial position) | 327,759 [derived, p.6] | 735,611 [derived, p.6] | 377,671 [derived, p.6] |
| grants and other receivables (Statement of financial position) | 508,053 [derived, p.6] | 535,883 [derived, p.6] | 982,431 [derived, p.6] |
| other current assets (Statement of financial position) | 113,834 [derived, p.6] | 132,519 [derived, p.6] | 81,830 [derived, p.6] |
| TOTAL CURRENT ASSETS (Statement of financial position) | 1,168,417 [extracted, p.6] | 1,695,671 [extracted, p.6] | 2,853,037 [extracted, p.6] |
| property and equipment, net (Statement of financial position) | 9,386,948 [derived, p.6] | 9,873,333 [derived, p.6] | 8,587,332 [derived, p.6] |
| other long-term assets (Statement of financial position) | 959,234 [derived, p.6] | 1,121,886 [derived, p.6] | 1,298,951 [derived, p.6] |
| TOTAL ASSETS (Statement of financial position) | 11,514,599 [extracted, p.6] | 12,690,890 [extracted, p.6] | 12,739,320 [extracted, p.6] |
| payables and accrued expenses (Statement of financial position) | 670,213 [derived, p.7] | 652,839 [derived, p.7] | 586,821 [derived, p.7] |
| deferred revenue (Statement of financial position) | 100,000 [derived, p.7] | absent (not printed, or not read) | absent (not printed, or not read) |
| current debt and leases (Statement of financial position) | 81,065 [derived, p.7] | 3,191,255 [derived, p.7] | 1,550,026 [derived, p.7] |
| other current liabilities (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL CURRENT LIABILITIES (Statement of financial position) | 851,278 [extracted, p.7] | absent (not printed, or not read) | absent (not printed, or not read) |
| long-term debt and leases (Statement of financial position) | 3,037,546 [derived, p.7] | absent (not printed, or not read) | absent (not printed, or not read) |
| other long-term liabilities (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL LIABILITIES (Statement of financial position) | 3,888,824 [extracted, p.7] | 3,844,094 [extracted, p.7] | 2,136,847 [extracted, p.7] |
| net assets without donor restrictions (Statement of financial position) | 7,625,775 [derived, p.7] | 8,846,796 [derived, p.7] | 10,491,266 [derived, p.7] |
| net assets with donor restrictions (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | 111,207 [derived, p.7] |
| TOTAL NET ASSETS (Statement of financial position) | 7,625,775 [extracted, p.7] | 8,846,796 [extracted, p.7] | 10,602,473 [extracted, p.7] |
| patient service revenue, net (Statement of activities) | 3,985,864 [derived, p.8] | 3,637,092 [derived, p.8] | 3,566,079 [derived, p.8] |
| pharmacy and 340B revenue (Statement of activities) | 1,103,364 [derived, p.8] | 2,045,959 [derived, p.8] | 1,383,939 [derived, p.8] |
| federal grants (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| other grants and contracts (Statement of activities) | 3,238,333 [derived, p.8] | 3,803,075 [derived, p.8] | 5,975,613 [derived, p.8] |
| contributions (Statement of activities) | 162,611 [derived, p.8] | 147,031 [derived, p.8] | 937,728 [derived, p.8] |
| other revenue (Statement of activities) | 179,239 [derived, p.8] | 123,138 [derived, p.8] | 274,750 [derived, p.8] |
| TOTAL REVENUE AND SUPPORT (Statement of activities) | 8,669,411 [extracted, p.8] | 9,756,295 [extracted, p.8] | 12,138,109 [extracted, p.8] |
| salaries and benefits (Statement of activities) | 6,877,154 [derived, p.8] | 7,415,662 [derived, p.8] | 6,379,448 [derived, p.8] |
| supplies and pharmaceuticals (Statement of activities) | 2,231,343 [derived, p.8] | 3,538,752 [derived, p.8] | 2,631,835 [derived, p.8] |
| purchased and professional services (Statement of activities) | 123,738 [derived, p.8] | 192,495 [derived, p.8] | 154,577 [derived, p.8] |
| occupancy (Statement of activities) | 47,030 [derived, p.8] | 50,796 [derived, p.8] | 50,849 [derived, p.8] |
| depreciation and amortization (Statement of activities) | 494,885 [derived, p.8] | 471,205 [derived, p.8] | 287,452 [derived, p.8] |
| interest (Statement of activities) | 265,585 [derived, p.8] | 202,749 [derived, p.8] | 31,082 [derived, p.8] |
| other expenses (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL EXPENSES (Statement of activities) | 10,039,735 [extracted, p.8] | 11,871,659 [extracted, p.8] | 9,535,243 [extracted, p.8] |
| OPERATING RESULT (Statement of activities) | -1,370,324 [extracted, p.8] | -2,115,364 [extracted, p.8] | 2,602,866 [extracted, p.8] |
| non-operating and other changes (Statement of activities) | 149,303 [derived, p.8] | 359,687 [derived] | 82,037 [derived] |
| CHANGE IN NET ASSETS (Statement of activities) | -1,221,021 [extracted, p.8] | -1,755,677 [extracted, p.9] | 2,684,903 [extracted, p.9] |
| net assets, beginning (Statement of activities) | 8,846,796 [extracted, p.8] | 10,602,473 [extracted, p.9] | 7,917,570 [extracted, p.9] |
| net assets, end (Statement of activities) | 7,625,775 [extracted, p.8] | 8,846,796 [extracted, p.9] | 10,602,473 [extracted, p.9] |

| Ratio | FY ending 2025-12-31 | FY ending 2024-12-31 | FY ending 2023-12-31 |
|---|---:|---:|---:|
| Days cash on hand | 8 days [plausible] | 9 days [plausible] | 56 days [plausible] |
| Current ratio | 1.37x [plausible] | absent [not computed] | absent [not computed] |
| Operating margin | -15.8% [plausible] | -21.7% [plausible] | 21.4% [plausible] |
| Total margin | -14.1% [plausible] | -18.0% [plausible] | 22.1% [plausible] |
| Patient revenue share | 46.0% [plausible] | 37.3% [plausible] | 29.4% [plausible] |
| Grant dependency | absent [not computed] | absent [not computed] | absent [not computed] |
| Salaries share | 68.5% [plausible] | 62.5% [plausible] | 66.9% [plausible] |
| Days in patient receivables | 30 days [plausible] | 74 days [plausible] | 39 days [plausible] |
| Debt to net assets | 0.41x [plausible] | absent [not computed] | absent [not computed] |
| Health center award share | absent [not computed] | absent [not computed] | absent [not computed] |

## Sources

HRSA Uniform Data System (awardee level; organization match Verified). CMS HCRIS cost reports, form CMS-224-14, as filed (the Medicare cost-report appendix). Federal Audit Clearinghouse single audits as filed (LA ESPERANZA CLINIC, INC.; FAC-11 template snapshot, SRC-FAC-001).

Methodology: https://astrelis.co/methodology · Data sources: https://astrelis.co/data-sources · Data philosophy: https://astrelis.co/data-philosophy

## Cite this page

Astrelis Atlas, "La Esperanza Clinic, Inc.", https://astrelis.co/providers/health_center/451902, release 2321a4fc37a7 (2026-10-22). Figures as filed in the named public sources; not audited by Astrelis.

Figures are as filed in the named public sources. Astrelis is not a CPA firm and performs no audit, review or attestation of any facility.